Today's most important downgrades
Tweet
Share
E-mail
Get Alerts JEF Hot Sheet
Rating Summary:
5 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0
Join SI Premium – FREE
Keefe, Bruyette & Woods downgraded Jefferies Group (NYSE: JEF) to Market Perform from Outperform ahead of the upcoming Q4 results announcement on Jan 9, 2023. Shares were down more than 4% intra-day.
Oppenheimer downgraded Fate Therapeutics (NASDAQ: FATE) to Perform from Outperform as part of a broader downgrade on the NK-cell therapy space. Shares fell more than 10% intra-day today.
Oppenheimer downgraded Celularity (NASDAQ: CELU) to Perform from Outperform. Shares were trading more than 8% lower intra-day today.
By Davit Kirakosyan
Want this type of news in real-time as it happens? Upgrade to StreetInsider.com Premium Here
Create E-mail Alert Related Categories
Downgrades, Hot ListRelated Entities
Keefe, Bruyette & Woods, Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
